Kurt Heininger

3.5k total citations
72 papers, 2.6k citations indexed

About

Kurt Heininger is a scholar working on Neurology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kurt Heininger has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Neurology, 16 papers in Physiology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kurt Heininger's work include Peripheral Neuropathies and Disorders (27 papers), Myasthenia Gravis and Thymoma (19 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Kurt Heininger is often cited by papers focused on Peripheral Neuropathies and Disorders (27 papers), Myasthenia Gravis and Thymoma (19 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Kurt Heininger collaborates with scholars based in Germany, Switzerland and United States. Kurt Heininger's co-authors include Klaus V. Toyka, Hans‐Peter Hartung, Bärbel Schäfer, Reinhard Hohlfeld, U. A. Besinger, Klaus V. Toyka, K. V. Toyka, Guido Stoll, Walter Fierz and I. Kalies and has published in prestigious journals such as Nature, Science and Brain.

In The Last Decade

Kurt Heininger

68 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Heininger Germany 31 1.4k 691 415 406 371 72 2.6k
Yasuo Kuroda Japan 30 769 0.6× 423 0.6× 716 1.7× 544 1.3× 686 1.8× 148 3.0k
W. W. Tourtellotte United States 23 503 0.4× 491 0.7× 593 1.4× 248 0.6× 224 0.6× 60 2.2k
Talma Brenner Israel 35 889 0.7× 400 0.6× 1.1k 2.7× 433 1.1× 942 2.5× 138 3.9k
Benedikt Volk Germany 30 642 0.5× 925 1.3× 1.1k 2.7× 723 1.8× 443 1.2× 68 4.4k
Philipp Albrecht Germany 33 956 0.7× 584 0.8× 1.1k 2.6× 267 0.7× 361 1.0× 162 3.7k
Lorraine A. DeGiorgio United States 18 763 0.6× 460 0.7× 807 1.9× 262 0.6× 678 1.8× 31 2.6k
Christiane S. Hampe United States 38 897 0.7× 653 0.9× 1.1k 2.6× 481 1.2× 486 1.3× 142 4.2k
Naoki Hattori Japan 30 767 0.6× 616 0.9× 596 1.4× 762 1.9× 132 0.4× 115 3.3k
J.‐J. Hauw France 31 1.3k 0.9× 465 0.7× 932 2.2× 872 2.1× 71 0.2× 91 3.2k
D Caparros-Lefèbvre France 23 1.0k 0.7× 503 0.7× 183 0.4× 714 1.8× 98 0.3× 58 2.2k

Countries citing papers authored by Kurt Heininger

Since Specialization
Citations

This map shows the geographic impact of Kurt Heininger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Heininger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Heininger more than expected).

Fields of papers citing papers by Kurt Heininger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Heininger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Heininger. The network helps show where Kurt Heininger may publish in the future.

Co-authorship network of co-authors of Kurt Heininger

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Heininger. A scholar is included among the top collaborators of Kurt Heininger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Heininger. Kurt Heininger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartung, Hans‐Peter, et al.. (2008). Neuromuskuläre Manifestationen der HIV-1- und HTLV-I-Infektionen*. DMW - Deutsche Medizinische Wochenschrift. 113(50). 1975–1981. 1 indexed citations
2.
Heininger, Kurt. (2002). The cerebral glucose-fatty acid cycle: Evolutionary roots, regulation, and (patho)physiological importance. International review of neurobiology. 51. 103–158. 12 indexed citations
3.
Reisberg, ‌Barry, Sanford I. Finkel, John E. Overall, et al.. (2001). The Alzheimer's Disease Activities of Daily Living International Scale (ADL-ISY). International Psychogeriatrics. 13(2). 163–181. 107 indexed citations
4.
Heininger, Kurt. (2000). A Unifying Hypothesis of Alzheimer's Disease. IV. Causation and Sequence of Events. Reviews in the Neurosciences. 11(Supplement). 213–328. 72 indexed citations
5.
Wehling, Peter, S. Cleveland, Kurt Heininger, et al.. (1996). Neurophysiologic Changes in Lumbar Nerve Root Inflammation in the Rat After Treatment With Cytokine Inhibitors. Spine. 21(8). 931–935. 22 indexed citations
6.
7.
Vass, K., Kurt Heininger, Bärbel Schäfer, Christopher Linington, & Hans Lassmann. (1992). Interferon‐γ potentiates antibody‐mediated demyelination in vivo. Annals of Neurology. 32(2). 198–206. 48 indexed citations
8.
Schmidt, Beate, Guido Stoll, Hans‐Peter Hartung, et al.. (1990). Macrophages but not schwann cells express ia antigen in experimental autoimmune neuritis. Annals of Neurology. 28(1). 70–77. 46 indexed citations
9.
Hartung, Hans‐Peter, Bärbel Schäfer, Peter H. van der Meide, et al.. (1990). The role of interferon‐gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Annals of Neurology. 27(3). 247–257. 102 indexed citations
10.
Heininger, Kurt, Walter Fierz, Bärbel Schäfer, et al.. (1989). ELECTROPHYSIOLOGICAL INVESTIGATIONS IN ADOPTIVELY TRANSFERRED EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN THE LEWIS RAT. Brain. 112(2). 537–552. 18 indexed citations
11.
Seitz, Rüdiger J., et al.. (1989). The blood–nerve barrier in Wallerian degeneration: A sequential long‐term study. Muscle & Nerve. 12(8). 627–635. 62 indexed citations
12.
Hartung, Hans‐Peter & Kurt Heininger. (1989). Non-specific mechanisms of inflammation and tissue damage in MS. Research in Immunology. 140(2). 226–233. 10 indexed citations
13.
Hartung, Hans‐Peter, et al.. (1989). Recombinant interleukin-1β stimulates eicosanoid production in rat primary culture astrocytes. Brain Research. 489(1). 113–119. 67 indexed citations
14.
Hartung, Hans‐Peter, Kurt Heininger, Bärbel Schäfer, & Klaus V. Toyka. (1988). Substance P Stimulates Release of Arachidonic Acid Cyclooxygenation Products from Primary Culture Rat Astrocytes. Annals of the New York Academy of Sciences. 540(1). 427–429. 14 indexed citations
15.
Heininger, Kurt, Bärbel Schäfer, Hans‐Peter Hartung, et al.. (1988). The role of macrophages in experimental autoimmune neuritis induced by a P2‐Specific T‐Cell line. Annals of Neurology. 23(4). 326–331. 45 indexed citations
16.
Hartung, Hans‐Peter, Kurt Heininger, & Klaus V. Toyka. (1988). Primary rat astroglial cultures can generate leukotriene B4. Journal of Neuroimmunology. 19(3). 237–243. 42 indexed citations
17.
Hartung, Hans‐Peter, Bärbel Schäfer, Tibor Diamantstein, et al.. (1988). Suppression of P2‐T‐Cell Line Mediated Experimental Autoimmune Neuritis by Interleukin‐2 Receptor Blockade. Annals of the New York Academy of Sciences. 540(1). 563–565. 1 indexed citations
18.
Hartung, Hans‐Peter, Bärbel Schäfer, Kurt Heininger, & Klaus V. Toyka. (1988). Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase. Annals of Neurology. 23(5). 453–460. 73 indexed citations
19.
Fierz, Walter, et al.. (1988). Synergism in the Pathogenesis of EAE Induced by an MBP‐Specific T‐Cell Line and Monoclonal Antibodies to Galactocerebroside or a Myelin Oligodendroglial Glycoproteina. Annals of the New York Academy of Sciences. 540(1). 360–363. 24 indexed citations
20.
Hartung, Hans-Peter, et al.. (1987). Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat. Neuroscience Letters. 83(1-2). 195–200. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuo Kuroda Breakdown of academic impact, for papers by W. W. Tourtellotte Breakdown of academic impact, for papers by Talma Brenner Breakdown of academic impact, for papers by Benedikt Volk Breakdown of academic impact, for papers by Philipp Albrecht Breakdown of academic impact, for papers by Lorraine A. DeGiorgio Breakdown of academic impact, for papers by Christiane S. Hampe Breakdown of academic impact, for papers by Naoki Hattori Breakdown of academic impact, for papers by J.‐J. Hauw Breakdown of academic impact, for papers by D Caparros-Lefèbvre
Rankless by CCL
2026